Accuracy of Calculated Free Valproate Levels in Adult Patients With Status Epilepticus
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To test the accuracy of an equation in adult patients with status epilepticus that calculates the free concentration of serum valproic acid (fVPA) from the total concentration of serum valproic acid (tVPA) and serum albumin.
Methods All adult patients with status epilepticus who were treated at a Swiss academic medical center between 2005 and 2018 with concurrent measurements of tVPA, fVPA, and serum albumin were included. fVPA was categorized as subtherapeutic, therapeutic (5–10 mg/L), or supratherapeutic. Agreement was defined as the proportion of measured and calculated fVPA falling within the same category.
Results Of 676 patients with status epilepticus, 104 had 506 measurements, with a median of 3 (interquartile range [IQR] 1.5–6.5) per patient. The median tVPA was 43.5 mg/L (27.4–63.6), with measured fVPA 9.1 mg/L (4.5–14.7) and calculated fVPA 10.1 mg/L (7.0–13.0), respectively. The median deviation of calculated from measured fVPA was −0.8 mg/L (−3.2 to 2.5) with 336 measurements >1 mg/L. While the association between measured and calculated fVPA was linear (regression coefficient 1.1, 95% confidence interval 0.9–1.2, p < 0.0001), the agreement on effective drug levels did not match in 39.8% of measurements regardless of serum albumin levels, with calculated fVPA overestimating measured fVPA in 30.4%. tVPA and serum albumin independently influenced the accuracy of the calculated fVPA in the multivariable model.
Conclusions Calculated fVPA is inaccurate when using the proposed equation in adult patients with status epilepticus, calling for drug monitoring based on measured fVPA in this context.
Glossary
- ASD=
- antiseizure drug;
- BUN=
- blood urea nitrogen;
- CI=
- confidence interval;
- fVPA=
- free valproic acid serum concentration;
- ICU=
- intensive care unit;
- IQR=
- interquartile range;
- STEP UP=
- Status Epilepticus Unicenter Population;
- tVPA=
- total valproic acid serum concentration;
- VPA=
- valproic acid
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received April 27, 2020.
- Accepted in final form August 20, 2020.
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sharon Poisson and Dr. Tiffany Brown
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Clinical/Scientific Notes
Subtherapeutic free phenytoin levels following fosphenytoin therapy in status epilepticusRoshan Koul, Dirk Deleu et al.Neurology, January 08, 2002 -
Research
IV fosphenytoin in obese patientsDosing strategies, safety, and efficacySarah L. Clark, Megan R. Leloux, Ross A. Dierkhising et al.Neurology: Clinical Practice, November 04, 2016 -
Views & Reviews
Seizures as adverse events of antibiotic drugsA systematic reviewRaoul Sutter, Stephan Rüegg, Sarah Tschudin-Sutter et al.Neurology, September 23, 2015 -
Articles
Optimizing therapy of seizures in stroke patientsPhilippe Ryvlin, Alexandra Montavont, Norbert Nighoghossian et al.Neurology, December 26, 2006